Since CCL20 showed the most prominent Ras-dependent upregulation among all tested chemokines, and previous findings supported a role for CXCL14 and CCL27 in tumour-immune surveillance, we decided to investigate further the role of CCL20 within the tumour microenvironment. The gene discussed is CCL20; the disease is neoplasm.